1 天前 - … reports about some cardiovascular drugs increasing risk of COVID-19 (particularly
ACEi and ARB), patient fear of going to pharmacies while COVID-19 was circulating in the …

1 天前 - … review of the acute and chronic cardiovascular complications secondary to COVID-19.
… of disease. Secondly, we reviewed the effects of COVID-19 syndrome in cardiovascular …

1 天前 - … shows that COVID-19 … cardiovascular disease 20 . It was reported that FH was
associated with an increased risk of long-term sustained cardiovascular risk following COVID-19 …

1 天前 - … COVID-19 can cause cardiac complications and the latter are associated with
poor prognosis and increased mortality. SARS-CoV-2 variants differ in their infectivity and …

2 天前 - … may help phenotype patients with advanced cardiopulmonary disease. Lung perfusion
… for COVID-19 at Johns Hopkins institutions. Older age and hospitalization for COVID-19 …

2 天前 - … positive study outcomes on the comparative impact of drug versus device trials and
the impact of the coronavirus disease 2019 (COVID-19) pandemic on the primary endpoint. …

2 天前 - … (T2DM) and cardiovascular disease (CVD). This work … COVID-19 infection in
patients with T2DM, cardiac manifestations of the disease, and current animal models of COVID-19…

2 天前 - … that acute cardiac injury during the hospitalization of COVID-19 patients was …
COVID-19 in it [33]. In vitro studies have shown that COVID-19 was able to induce injury to cardiac …

2 天前 - … For a long time to come with COVID-19 era, primary care … frailty, cardiovascular
diseases and mental diseases related to … COVID-19 pandemic, but also PCC and cardiovascular …

3 天前 - Transcatheter aortic valve replacement (TAVR) has been an amazingly disruptive
innovation for treatment of severe aortic stenosis in the US adult population, transforming …